Actually I can recall a number of small sales of RVX in the last several months by Morgan Stanley. Upon a quick check, in the last month they have made 8 such trades between $1.36 and $1.61. On another note, thank you BDAZ for your list of questions to management, I hope they answer more than a few of them. Personally I am most curious about details regarding the trials for other indications since they, again, have made very broad reference to them in the last little video which in my view was pretty fluffy.